Home » ETF » BBC

BBC - BioShares Biotechnology Clinical Trials ETF

Stock Price: $49.16 USD 1.65 (3.47%)
Updated Apr 21, 2021 4:00 PM EDT - Market closed
After-hours: $49.16 0.00 (0.00%) Apr 21, 8:00 PM
Assets $46.71M
NAV $49.16
Expense Ratio 0.79%
PE Ratio n/a
Beta (5Y) 1.44
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date Dec 20, 2017
1-Year Return -
Trading Day April 21
Last Price $49.16
Previous Close $47.51
Change ($) 1.65
Change (%) 3.47%
Day's Open 47.38
Day's Range 48.13 - 49.16
Day's Volume 8,691
52-Week Range 33.02 - 62.60

Fund Description

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Asset Class
Portfolio-Multi Asset
Sector
Biotech
Region
North America
Inception Date
Dec 16, 2014
Exchange
NYSEARCA
Ticker Symbol
BBC
Index Tracked
BioShares Biotechnology Clinical Trials Index

Top 10 Holdings

14.56% of assets
NameSymbolWeight
AmyrisAMRS3.14%
Rubius TherapeuticsRUBY1.76%
Five Prime Therapeutics IncFPRX1.38%
Bny Mellon Cash Reserve UsdCBI.MI1.34%
Dynavax TechnologiesDVAX1.23%
Applied Molecular TransportAMTI1.18%
ProthenaPRTA1.18%
Cara TherapeuticsCARA1.17%
Morphic HoldingMORF1.16%
ImmunityBioIBRX1.02%
View More Holdings

News

Hide News
  • All
  • Videos
  • Conversation

These funds could be the best ways for investors to tap the opportunity arising from the Bristol Myers-MyoKardia deal and will likely see smooth trading in the months to come.

Other tickers mentioned: ARKG, SBIO, XBI, XPH
6 months ago - Zacks Investment Research

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

Other tickers mentioned: BTEC, IBBJ, IDNA, MRNS, NVUS, PTH, SAVA ...
7 months ago - Zacks Investment Research

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

Other tickers mentioned: BTEC, IBBJ, IDNA
7 months ago - Zacks Investment Research

The ALPS Medical Breakthroughs ETF (SBIO) is one of many biotechnology ETF garnering attention this year amid the race to defeat the coronavirus, but SBIO also offers investors allure that will extend b...

Other tickers mentioned: IBB, SBIO
8 months ago - ETF Trends

With a slew of news to start off the month and quarter, biotech equities and ETFs are moving higher on Wednesday with optimism over developments on the coronavirus vaccine front. The Dow Jones Industria...

Other tickers mentioned: BBH, IBB
9 months ago - ETF Trends

The S&P 500 is sitting on an impressive 16.36% gain with just one day left in the second quarter.

Other tickers mentioned: ACES, ARGT
9 months ago - Benzinga

Biotechnology ETFs, including the ALPS Medical Breakthroughs ETF (SBIO), are on torrid paces in the second quarter. Yes, some of that bullishness is attributable to the industry’s efforts to vanquish th...

Other tickers mentioned: IBB, SBIO
10 months ago - ETF Trends

Below are four ETFs that buoyed up on strong earnings results.

Other tickers mentioned: IBUY, ITB, WCLD
10 months ago - Zacks Investment Research

This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

10 months ago - Zacks Investment Research

Biotechnology sector-related exchange traded funds led the charge on Monday, with some breaking out to new highs. Among the best performing non-leveraged ETFs of Monday, the ARK Genomic Revolution ETF (...

Other tickers mentioned: XBI
11 months ago - ETF Trends

Something's been brewing in the health care sector, the second-largest group in the S&P 500.

Other tickers mentioned: ARKG, BTEC
11 months ago - Benzinga

Failure to Launch: The ETF Built to Fight the Coronavirus That Never Came to Be

YouTube video

Bloomberg's Eric Balchunas and Scarlet Fu break down the Virtus LifeSci Biotech Clinical Trials ETF (ticker: BBC) with Paul Yook, CIO of LifeSci Venture Partners.

1 year ago - Bloomberg Markets and Finance

The best Growth ETFs for Q1 2020 are XLK, BBC, and VGT.

Other tickers mentioned: VGT, XLK
1 year ago - Investopedia

The best Healthcare ETFs for Q1 2020 are BBC, SBIO, and KURE.

Other tickers mentioned: KURE, SBIO
1 year ago - Investopedia

Despite concerns of a spreading coronavirus out of China, biotechnology stocks and sector-related ETFs are not enjoying the usual bump on hopes of developing new treatments to counter the contagion. Amo...

Other tickers mentioned: IBB, XBI
1 year ago - ETF Trends

These biotech ETFs could be standouts again in 2020, particularly if genomics stocks rally

Other tickers mentioned: ARKG, PBE
1 year ago - InvestorPlace

These smart-beta ETFs beat the broader market with ease in 2019.

Other tickers mentioned: FTXL, GOAU, QTUM
1 year ago - Zacks Investment Research

With just two trading days left in 2019, the SPDR S&P 500 ETF, the world's largest exchange traded fund, is higher by 29.19% this year, meaning the S&P 500 is on pace for its best annual performance sin...

Other tickers mentioned: GOAU, PALL, TAN, XSD
1 year ago - Benzinga

Some biotech stocks have contributed materially to the Nasdaq's 1000-point gain since Aug 27, 2018 and helped it notch a record 9,000 on Dec 26.

Other tickers mentioned: DWAQ, XPH
1 year ago - Zacks Investment Research

As there have been winners in many corners of the space, we highlight nine ETFs from different zones that have outperformed so far this year. These are expected to continue outperforming, provided the f...

Other tickers mentioned: GOAU, ITB, PBW, QTUM, SILJ, SMH, TAN ...
1 year ago - Zacks Investment Research

Inside the top and worst-performing ETFs of the fourth quarter.

Other tickers mentioned: CHIR, GAZ, JO, PAK, PIN, POTX, VXX
1 year ago - Zacks Investment Research

While Wall Street is surging this quarter, these sector ETFs offered even better performances to beat the market.

Other tickers mentioned: GNOM, IEZ, PXJ, SBIO, SIL, SILJ, SMH ...
1 year ago - Zacks Investment Research

Can biotech ETFs repeat its success story of 2019 in the election year of 2020?

Other tickers mentioned: CNCR, HTEC, IBB, IDNA, PBE, SBIO, XBI
1 year ago - Zacks Investment Research

Braving all hurdles including recession fears, trade dispute, Brexit and geopolitical tensions, Wall Street has enjoyed a huge rally this year with all the three major indices hitting record highs lately.

Other tickers mentioned: ITB, PBW, SMH, TAN
1 year ago - Zacks Investment Research

We take a look at the best performing areas of the market

Other tickers mentioned: AMD, ENPH, NVDA, PALL, SEDG, SOXX, TAN
1 year ago - Zacks Investment Research

Wall Street continued its uptrend last week with the S&P 500 and Nasdaq hitting new highs, climbing 0.7% and 0.9%, respectively.

Other tickers mentioned: COPX, IEZ, MLPG, POTX
1 year ago - Zacks Investment Research

ETF Trends CEO Tom Lydon discussed the Virtus LifeSci Biotech Clinical Trials ETF (BBC) on this week’s “ETF of the Week” podcast with Chuck Jaffe on the MoneyLife Show. BBC seeks investment results that...

1 year ago - ETF Trends

Following the new deals in the healthcare space, a few biotech ETFs hit new highs.

Other tickers mentioned: CNCR, GNOM, IBB, SBIO, XBI
1 year ago - Zacks Investment Research

Head: Why Biotech ETFs are Rising

YouTube video

Increasing M&A deals and cutting edge therapies are driving biotech ETFs higher.

Other tickers mentioned: ARKG, IBB, SBIO, XBI
1 year ago - Zacks Investment Research

Investors have been piling into exchange traded funds again this year, mostly pure beta, core equity and fixed income funds.

1 year ago - Benzinga

November was kind to the stock market with major bourses logging the best monthly gain since June.

Other tickers mentioned: JJN, JO, PAK, POTX
1 year ago - Zacks Investment Research

Last week was downbeat for the broader market owing to uncertainty over the signing of the ???phase-one?

Other tickers mentioned: DFND, EGPT, FTXL, INR, POTX, PSCE, SGDJ
1 year ago - Zacks Investment Research

Healthcare bounced back with an outperformance starting the fourth quarter.

Other tickers mentioned: CNCR, GNOM, IHF, IRWD, JNCE, OSMT, SBIO ...
1 year ago - Zacks Investment Research

The S&P 500 hit record highs last week, with the index rising for the fourth consecutive week, marking its longest winning streak since March.

Other tickers mentioned: ARKG, PRNT, VETS, XSD
1 year ago - Zacks Investment Research

The healthcare sector, which has been the second-worst performer among the 11 major S&P 500 sectors this year, took the center stage this month with some outperformance compared to other sectors.

Other tickers mentioned: GNOM, IHF, SBIO, XBI, XPH
1 year ago - Zacks Investment Research

The biotech sector got a boost over the past week from a flurry of positive news including trial results and deal activities.

Other tickers mentioned: BBP, BTEC, HEPA, SBIO
1 year ago - Zacks Investment Research